PRCT Live signals | Maximize Profits with Getagraph.com

BUY 102458 min ago

@ $50.10

Issued: 14 Feb 2024 @ 15:44

Return: 4.35%

Previous signal: Feb 14 - 09:32

Previous signal: Sell

Return: 0.62 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	417 107
Average Volume	484 220
Market Cap	2.66B
EPS	$0 ( 2024-02-27 )
Next earnings date	( $-0.550 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-23.34
ATR14	$0.0600 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Wood Larry L	Buy	5 284	Stock Option (Right to Buy)
2024-04-18	Wood Larry L	Buy	3 054	Common Stock
2024-03-06	Zadno Reza	Buy	48 575	Common Stock
2024-03-06	Zadno Reza	Buy	42 311	Stock Option (Right to Buy)
2024-03-06	Waters Kevin	Buy	13 275	Common Stock

INSIDER POWER
2.97
Last 100 transactions
Buy: 687 056 \| Sell: 915 626

Volume Correlation

Long: -0.10 (neutral)

Short: -0.80 (moderate negative)

Signal:(38.59) Neutral

PROCEPT BioRobotics Correlation

10 Most Positive Correlations
INCR	0.888
TRIT	0.881
RPRX	0.88
JG	0.877
PROC	0.875
NCBS	0.874
VORB	0.873
PCSA	0.872
SIGA	0.872
BNTX	0.87

10 Most Negative Correlations
ESCA	-0.901
GBRG	-0.896
BREZ	-0.888
LMRKO	-0.887
ARIZ	-0.885
CNGL	-0.884
WTMA	-0.883
GENQ	-0.882
CMPO	-0.882
IQ	-0.879

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PROCEPT BioRobotics Correlation - Currency/Commodity

0.59
( weak )

0.23
( neutral )

0.00
( neutral )

0.46
( neutral )

0.28
( neutral )

0.55
( weak )

PROCEPT BioRobotics Financials

Annual	2023
Revenue:	$136.19M
Gross Profit:	$71.05M (52.17 %)
EPS:	$-2.24

Q4	2023
Revenue:	$43.58M
Gross Profit:	$19.94M (45.75 %)
EPS:	$-0.540

Q3	2023
Revenue:	$35.10M
Gross Profit:	$18.87M (53.77 %)
EPS:	$-0.510

Q2	2023
Revenue:	$33.10M
Gross Profit:	$18.43M (55.67 %)
EPS:	$-0.560

Financial Reports:

No articles found.

PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Realtime updates for PROCEPT BioRobotics [PRCT]

Upcoming Earnings Alert